课题基金 / 基金详情

SBIR Phase I: Developing Nanopores to Facilitate Delivery of Intracellular Cryoprotectants for Biopreservation at Low Temperature

SBIR Phase I: Developing Nanopores to Facilitate Delivery of Intracellular Cryoprotectants for Biopreservation at Low Temperature
SBIR 第一阶段:开发纳米孔以促进细胞内冷冻保护剂的递送以实现低温生物保存
批准号:
1622240
负责人:
Xiaoxi Wei
金额:
$22.5万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2018-02-28

项目摘要

项目成果

Xiaoxi Wei的其他基金

相似基金

相关文献

中文摘要
翻译
该SBIR第一阶段项目旨在开发一种尖端纳米技术,该技术将极大地增强干细胞、复杂组织和器官等再生药物的生物保存。这种技术有可能永远改变再生医疗保健。它将改变按需细胞和组织的生物库,并改善大规模创伤护理和先进的个性化医疗程序。在再生医学中,几乎所有级别的再生医学都需要生物保存,包括原始材料的获取、分离、储存和将最终产品运送给患者。然而,至关重要的是,该领域缺乏安全有效地保存这些组织和药物的能力,严重限制了产品的保质期。没有任何地方比器官移植更明显地缺乏生物库技术,在器官移植中,捐赠者和接受者之间的时间窗口(4-7小时)不足以正确匹配捐赠、筛查病原体或运输距离。死于器官早衰的人比死于癌症的人多。使美国能够在零下的温度下安全地储存器官,将显著提高国民医疗保健水平。美国面临着强大的商业和竞争力理由,需要投资于再生医学的方方面面,包括器官疗法。冷冻保存解决方案将间接为医疗保健系统、患者和医疗保险公司节省大量成本,在美国,再生医学治疗每年节省的成本估计接近2500亿美元。目前生物保存技术的细胞毒性很大程度上与低效的冷冻保护剂和冷却期间跨细胞膜的水输送有关,从而导致冰层形成造成不可修复的细胞损伤。该项目的目标是建立一种完全不同的低温保护剂优化方法,通过开发第一个受生物启发的纳米孔作为跨膜巨型高速公路,促进在低温保存期间安全有效地在细胞内运送和移除低温保护剂。过去的研究已经证明了通过基于多个氢键、偶极-偶极和芳香族pi-pi堆积作用的相互作用以及它们自身插入到脂质双层中,通过强制堆积形状持久的大环来构建定义良好的纳米管组件的可靠性。当蛋白质通道在3°C或以下发生故障时,这些合理设计的有机纳米孔将作为选择性跨膜通道,从而显著缩短细胞达到无冰低温保存温度的暴露时间。保存后的细胞产量和活力将通过减少细胞内结冰而大大提高。在复温后,这些有机纳米孔将有助于快速去除低温保护剂。在生理温度下,纳米孔将被密封,并被从系统中洗出,从而产生低毒性。纳米孔的功能和效果将通过基于脂质体的葡萄糖转运、基于细胞的毒性和基于细胞的冷冻保存试验来检验。
英文摘要
This SBIR Phase I project aims to develop a cutting-edge nanotechnology that will greatly enhance biological preservation of regenerative medicines such as stem cells, complex tissues, and organs. Such a technology has the potential to changing regenerative healthcare forever. It would change biobanking for on-demand cells and tissues and improve mass trauma care and advanced personalized medical procedures. Biopreservation is required in regenerative medicine at nearly all levels in the acquisition of source material, isolation, storage and shipment of a final product to patient. Yet, critically, the field lacks the ability to safely and efficiently preserve these tissues and medicines severely limiting product shelf life. Nowhere is the absence of a biobanking technology more palpable than organ transplantation, where the time window between donor and recipient (4-7 hours) is not enough to properly match donations, screen for pathogens, or transport distances. More people will die from premature organ failure than cancer. Enabling the United States to safely bank organs at subzero temperature will significantly enhance national healthcare. The US faces strong commercial and competitiveness reasons to invest in all facets of regenerative medicine, including organ therapies. Cryopreservation solutions would indirectly enable significant savings to the healthcare system, the patient, and healthcare insurance companies with the cost savings from regenerative medicine treatments estimated to be nearly $250 billion per year in the U.S. The cytotoxicity of current biopreservation techniques is largely associated with inefficient cryoprotective agent and water delivery across the cell membrane during cooling leading to irreparable cell damage from ice formation. The goal of this project is to establish a fundamentally different approach to cryoprotective agent optimization by developing first-in-the-field bioinspired nanopores as transmembrane mega highways to facilitate safe and efficient intracellular delivery and removal of cryoprotective agents during cryopreservation. Past research has demonstrated the reliability of constructing well-defined nanotubular assemblies via the enforced stacking of shape-persistent macrocycles based on the interplay of multiple hydrogen-bonding, dipole-dipole, and aromatic pi-pi stacking interactions and their self-insertion into lipid bilayers. These rationally designed organic nanopores will serve as selective transmembrane channels when protein channels malfunction at or below 3 °C. As a result, the cell's exposure time to reach ice-free cryopreservation temperature will be significantly reduced. Post-preservation cell yield and viability will be greatly improved by reducing intracellular ice formation. Upon rewarming, these organic nanopores will facilitate rapid removal of the cryoprotective agents. At physiological temperature, the nanopores will seal off, and be washed out from the system resulting in low toxicity. Nanopore function and effect will be examined using liposome-based glucose transport, cell-based toxicity and cell-based cryopreservation assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR Phase II: Dynamic Nanopores Enabling Non-toxic Cryopreservation to Advance Centralized Manufacturing & Transport of Regenerative Medicines
  • 批准号:
    1831084
  • 项目类别:
    Standard Grant
  • 资助金额:
    $74.33万
  • 财政年份:
    2018
  • 负责人:
    Xiaoxi Wei
  • 依托单位:
国内基金
海外基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YUICHIRO NAKAI
  • 依托单位:
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    3350万元
  • 批准年份:
    2019
  • 负责人:
    刘衍文
  • 依托单位:
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2018
  • 负责人:
    张里
  • 依托单位:
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究